Meeting
2022 ASCO Annual Meeting
Impact of the COVID-19 pandemic on stage at diagnosis of patients with breast cancer: An analysis of 11,752 patients from Oncoclínicas.
Authors
Cristiano Augusto Andrade de Resende
Grupo Oncoclinicas, São Paulo, Brazil
Cristiano Augusto Andrade de Resende , Rodrigo Dienstmann , Carlos H. Barrios , Bruno Lemos Ferrari , Aline Coelho Goncalves , Fanny Cascelli , Andreza Karine Souto , Matheus Costa e Silva , Heloisa Cruz , Leandro Carvalho Oliveira , Diocesio Alves Pinto de Andrade , Eduardo Camargo Millen , Felipe Zerwes , Tomas Reinert , Paulo Moraes , Max S. Mano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10559)
DOI
10.1200/JCO.2022.40.16_suppl.10559
Abstract #
10559
Poster Bd #
435
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Advanced pancreatic cancer outcomes and the impact of COVID-19 pandemic: The experience of an academic cancer center.
First Author: Christian Adams-Carey
Poster
2023 ASCO Annual Meeting
Longitudinal MRI-based fusion novel model to predict pathological complete response in breast cancer treated with neoadjuvant chemotherapy: A multicenter, retrospective study.
First Author: Kun Wang
Poster
2022 ASCO Quality Care Symposium
Evaluating nurses' time to response by severity and cancer stage in a remote symptom monitoring program.
First Author: Jeffrey Franks
Poster
2022 ASCO Annual Meeting
Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after prior treatment (tx) with FUL in patients (pts) with advanced breast cancer (ABC): A real-world (RW) analysis.
First Author: Joyce O'Shaughnessy